tofacitinib,ustekinumab
Janssen,Pfizer
['ibd']
identifying avenues for early intervention and tailoring therapy to optimize response will be key in maximizing the impact of new ibd treatments, says . read more #ddw2023 
The latest clinical news and research from experts at @nyulangone. Ranked #2 Best Medical School and #3 Best Hospital in the nation by U.S. News & World Report.